Evolus (EOLS) Change in Receivables (2019 - 2026)
Evolus (EOLS) posted Change in Receivables of -$2.2 million for Q1 2026, down 144.95% on a QoQ basis from $4.8 million in Q4 2025, and down 361.73% year-over-year from $823000.0 in Q1 2025.
Evolus (EOLS) Change in Receivables (2019 - 2026) Analysis & Trends
Evolus' Change in Receivables history runs 8 years deep, the most recent figure standing at -$2.2 million for Q1 2026.
- Quarterly Change in Receivables fell 361.73% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (down 48.37% YoY) and the FY2025 annual result came in at $11.5 million, down 41.29% from the prior year.
- Change in Receivables was -$2.2 million for Q1 2026 at Evolus, down from $4.8 million in the prior quarter.
- Across five years, Change in Receivables topped out at $9.5 million in Q2 2024 and bottomed at -$2.2 million in Q1 2026.
- A 5-year average of $2.8 million and a median of $2.5 million in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables jumped 2435.76% — and 2026, when it plunged 361.73%.
- Evolus' Change in Receivables stood at $1.8 million in 2022, then slumped by 91.44% to $151000.0 in 2023, then soared by 2435.76% to $3.8 million in 2024, then gained by 25.15% to $4.8 million in 2025, then sank by 144.95% to -$2.2 million in 2026.
- Business Quant data shows EOLS's Change in Receivables at -$2.2 million in Q1 2026, $4.8 million in Q4 2025, and $4.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | -2.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.15 Mn |
| Mar 31, 2026 | -2.15 Mn |
| Dec 31, 2025 | 4.79 Mn |
| Dec 31, 2025 | 4.79 Mn |
| Sep 30, 2025 | 4.94 Mn |
| Sep 30, 2025 | 4.94 Mn |
| Jun 30, 2025 | 958,000.00 |
| Jun 30, 2025 | 958,000.00 |
| Mar 31, 2025 | 823,000.00 |
| Mar 31, 2025 | 823,000.00 |
| Dec 31, 2024 | 3.83 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Sep 30, 2024 | 2.38 Mn |
| Sep 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 9.49 Mn |
| Jun 30, 2024 | 9.49 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Dec 31, 2023 | 151,000.00 |
| Dec 31, 2023 | 151,000.00 |